Cargando…
Precision immunointerception of EGFR-driven tumorigenesis for lung cancer prevention
Epidermal growth factor receptor (EGFR) mutations occur in about 50% of lung adenocarcinomas in Asia and about 15% in the US. EGFR mutation-specific inhibitors have been developed and made significant contributions to controlling EGFR mutated non-small cell lung cancer. However, resistance frequentl...
Autores principales: | Pan, Jing, Xiong, Donghai, Zhang, Qi, Palen, Katie, Shoemaker, Robert H., Johnson, Bryon, Sei, Shizuko, Wang, Yian, You, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982083/ https://www.ncbi.nlm.nih.gov/pubmed/36875137 http://dx.doi.org/10.3389/fimmu.2023.1036563 |
Ejemplares similares
-
Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer
por: Huang, Mofei, et al.
Publicado: (2022) -
Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention
por: Lee, Sang Beom, et al.
Publicado: (2023) -
Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA
por: Pan, Jing, et al.
Publicado: (2021) -
Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator
por: Pan, Jing, et al.
Publicado: (2019) -
Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
por: Pan, Jing, et al.
Publicado: (2017)